Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to observe lacrimal fluid condition (tear film break-up time)
chronologically after a single dose of AL-43546 ophthalmic products（0.15%, 0.25% and
vehicle）and 0.1% sodium hyaluronate ophthalmic solution and compare lacrimal fluid retention
time between them.